MYC and hematologic disorder: antitumor, cell membrane and steroid enzyme creationinflammatory responses and blood pressure regulationtelomerase substrate primer inhibitionPKC inhibitionhTERT and c-Myc mRNA down-regulationtelomerase activity decreaseapoptosis and progression of hematologic malignancies controlneutropenic enterocolitis and cardiotoxicity prevention